A data‐driven algorithm to determine 1 H ‐ MRS basis set composition
Open Access
- 16 August 2025
- journal article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 95 (1) , 20-37
Abstract
Purpose: Metabolite amplitude estimates derived from linear combination modeling of MR spectra depend on the precise list of constituent metabolite basis functions used (the “basis set”). The absence of clear consensus on the “ideal” composition or objective criteria to determine the suitability of a particular basis set contributes to the poor reproducibility of MRS. In this proof‐of‐concept study, we demonstrate a novel, data‐driven approach for deciding the basis‐set composition using Akaike information criteria (AIC). Methods: We have developed an algorithm that iteratively adds metabolites to the basis set using iterative modeling, informed by AIC scores. We investigated two quantitative “stopping conditions,” referred to as max‐AIC and zero‐amplitude, and whether to optimize the selection of basis set on a per‐spectrum basis or at the group level. The algorithm was tested using two groups of synthetic in vivo‐like spectra representing healthy brain and tumor spectra, respectively, and the derived basis sets (and metabolite amplitude estimates) were compared to the ground truth. Results: All derived basis sets correctly identified high‐concentration metabolites and provided reasonable fits of the spectra. At the single‐spectrum level, the two stopping conditions derived the underlying basis set with 84% to 88% accuracy. When optimizing across a group, basis set determination accuracy improved to 89% to 92%. Conclusion: Data‐driven determination of the basis set composition is feasible. With refinement, this approach could provide a valuable data‐driven way to derive or refine basis sets, reducing the operator bias of MRS analyses, enhancing the objectivity of quantitative analyses, and increasing the clinical viability of MRS.Keywords
Funding Information
- Deutsche Krebshilfe
- National Institutes of Health (K99 AG080084, P41 EB031771, R00 AG062230, R01 EB016089, R01 EB023963, R01 EB035529, R21 EB033516)
This publication has 46 references indexed in Scilit:
- MRSCloud: A cloud‐basedMRStool for basis set simulationMagnetic Resonance in Medicine, 2022
- The influence of cystathionine on neurochemical quantification in brain tumor in vivo MR spectroscopyMagnetic Resonance in Medicine, 2022
- Results and interpretation of a fitting challenge for MR spectroscopy set up by the MRS study group of ISMRMMagnetic Resonance in Medicine, 2021
- Adaptive baseline fitting for MR spectroscopy analysisMagnetic Resonance in Medicine, 2020
- Water removal in MR spectroscopic imaging with L2 regularizationMagnetic Resonance in Medicine, 2019
- In vivo 1H MRS detection of cystathionine in human brain tumorsMagnetic Resonance in Medicine, 2019
- Methodological consensus on clinical proton MRS of the brain: Review and recommendationsMagnetic Resonance in Medicine, 2019
- Weighted averaging in spectroscopic studies improves statistical powerMagnetic Resonance in Medicine, 2017
- Advanced processing and simulation of MRS data using the FID appliance (FID‐A)—An open source, MATLAB‐based toolkitMagnetic Resonance in Medicine, 2015
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993